Binding Database

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Fused Thiazin-3-ones as KCa3.1 Inhibitors.

Temple University

Ion channels as therapeutic targets: a drug discovery perspective.

Pfizer

Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5.

Astrazeneca

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

Icagen

Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.

Abbott Laboratories

Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.

4Sc

Novel Potassium Channel Inhibitors.

Temple University

Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.

Bristol-Myers Squibb

Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.

Agouron Pharmaceuticals

Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.

Dupont Pharmaceuticals